NDC11 71921017061
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 71921-0170-61 | 71921-0170 |
| 71921-170-61 | 71921-170 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sumatriptan | SUMATRIPTAN | Florida Pharmaceutical Products, LLC. | 267dadc1-6960-4d8b-88ef-86be9c5f7159 | 2021-11-13 | Warnings, Adverse reactions | 71921-170-61 71921-170 71921017061 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.